Recent research suggests that blood levels of Lipoprotein(a) or Lp(a) may be an important marker for the risk developing of heart disease. However, measurements of Lp(a) are not widely available and are seldom used in routine clinical practice.
The most dangerous particle when it comes to heart disease is genetically-determined, meaning your family gave it you. Insurance companies often refuse to pay to have it tested so most of the millions of people who have it are unaware. It is called “Lp little a or Lp(a).” It is small and very dense and gets into the lining of the arteries easily. Unfortunately, neither standard medications for lowering bad cholesterol or nutrition lower the particle.
Lp(a) is a strong risk factor for CVD. However, the lack of clinical trial data has resulted in Lp(a) being largely ignored by clinical guidelines assessing the prevention of CVD.
In 2010, the European Atherosclerosis Society (EAS) consensus panel recommended screening for elevated Lp(a), in people with moderate to high risk of cardiovascular disease.
Here’s how Lp(a) levels are looked at in terms of risk:
Desirable: < 14 mg/dL (< 35 nmol/l)
Borderline risk: 14 – 30 mg/dL (35 – 75 nmol/l)
High risk: 31 – 50 mg/dL (75 – 125 nmol/l)
Very high risk: > 50 mg/dL (> 125 nmol/l)
You can CLICK HERE and order your Lipoprotein A test direct for a much lower price and then you can discuss this with your doctor.
